HIV-1 CA mutations selected during passage in rhTRIM5α-expressing cells decrease sensitivity to rhTRIM5α. by Steven J. Soll (270043)

Mfsd2a KO mice have decreased liver TG with normal liver metabolism. by Justin H. Berger (297156)

Albumin degradation in podocytes decreased with lysosome inhibition, but not proteasome inhibition. by John M. Carson (577297)

ASO treatment suppresses the palbociclib-mediated induction of MEG3 and decrease in cell proliferation in SK-MES-1 cells. by Traci L. Kruer (3342425)

Percentage of biomass that decreased in relation to the control after the incubation period (5 days) of the experimental cultures containing 100 ml of each of the three different <... by Fabiana Araújo (5052323)

PF treatment decreases the levels of IL-1β(A) and TNFα(B) in plasma. by Ruo-Bing Guo (298949)

Fig 9 - by Wenping Dong (3854437)

Subjects:

Fig 4 - by Wenping Dong (3854437)

Subjects:

Fig 8 - by Wenping Dong (3854437)

Subjects:

Fig 7 - by Wenping Dong (3854437)

Subjects:

Fig 3 - by Wenping Dong (3854437)

Subjects:

Fig 6 - by Wenping Dong (3854437)

Subjects:

Loss of nsp14-ExoN activity decreases recombination frequency and alters recombination junction patterns across the genome. by Jennifer Gribble (10005444)

Initial RBC dominant clot compaction in the <i>in vitro</i> MCA model without and with collateral with alteplase applied at clinically relevant concentration (1.3 mg L^-1... by Sandra Thalerová (11434762)

TIMP3 overexpression decreases tibial bone mechanical properties from macroscale to nanoscale mechanics. by Blandine Poulet (2939877)

“…<p>A, Von Kossa staining of tibia epiphysis and metaphysis of WT and TIMP3 Tg/Tg mice showed decreased trabecular bone in TIMP3 Tg/Tg mice (Magnification x2). …”

Decreases in locomotor responses to a single METH injection in <i>Ptprz</i>-KO mice. by Akihiro Fujikawa (122649)

HO-1 overexpression decreases Nox4 activity in C-20/A4 chondrocytes. by Francis Rousset (424375)

Validation of a New Scoring Scale for Behavioral Assessment of L‑Dopa-Induced Dyskinesia in the Rat: A New Tool for Early Decision-Making in Drug Development by Simon Loiodice (4715610)

“…Unilaterally 6-OHDA-lesioned rats were administered L-dopa (20 mg/kg) and benserazide (5 mg/kg) daily for 3 weeks starting 4 weeks postlesion, then coadministered with amantadine (20–30–40 mg/kg). …”

Increased ROS level decreases RLS in respiratory-deficient cells. by Dae-Gwan Yi (5410298)

Immobility time of NrbKO and SpKO mice in the forced swim test (FST) at 3–5 months of age (young adult). by Huiying Wu (1587136)